PI
ANIP icon

PineBridge Investments’s ANI Pharmaceuticals ANIP Stock Holding History

PineBridge Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,113
Closed -$59K – 1039
2017
Q3 		$59K Buy
1,113
+56
+5% +$2.67K ﹤0.01% 1029
2017
Q2 		$49K Buy
1,057
+20
+2% +$965 ﹤0.01% 1033
2017
Q1 		$52K Buy
1,037
+27
+3% +$1.52K ﹤0.01% 1024
2016
Q4 		$61K Hold
1,010
– – ﹤0.01% 1055
2016
Q3 		$67K Buy
1,010
+86
+9% +$5.38K ﹤0.01% 896
2016
Q2 		$52K Buy
924
+32
+4% +$1.56K ﹤0.01% 945
2016
Q1 		$30K Sell
892
-126
-12% -$4.27K ﹤0.01% 1012
2015
Q4 		$46K Sell
1,018
-32
-3% -$1.38K ﹤0.01% 949
2015
Q3 		$42K Buy
1,050
+100
+11% +$5.69K ﹤0.01% 973
2015
Q2 		$59K Sell
950
-1,218
-56% -$72.5K ﹤0.01% 907
2015
Q1 		$136K Buy
+2,168
New +$132K 0.01% 844

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PineBridge Investments's ANIP Position: Q4 2017 in Review

PineBridge Investments sold out of ANI Pharmaceuticals (ANIP) in Q4 2017, closing a stake of 1,113 shares — an estimated $59K sold.

PineBridge Investments first reported a position in ANIP in Q1 2015 and held it in 11 quarters. The position peaked at $136K in Q1 2015. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

  • PineBridge Investments reported no remaining ANI Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • PineBridge Investments sold 1,113 ANI Pharmaceuticals shares in Q4 2017, an estimated $59K.
  • PineBridge Investments first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • PineBridge Investments's ANI Pharmaceuticals position peaked at $136K in Q1 2015.
  • 163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on PineBridge Investments's 13F filing for Q4 2017, filed 9 Feb 2018.